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Cell-Based Assays in Cancer 
Research
Biba Vikas and Sukumaran Anil
Abstract
Cell growth is referred to as cell proliferation, that is, the increase in cell num-
bers during repeated cell division. Cell growth can be defined as the enlargement 
of cell volume, which might take place in the absence of cell division. Growth and 
reproduction are features of cells in all living organisms. All cells reproduce by 
dividing into two, with each parental cell giving rise to two daughter cells each time 
they divide. Various genes are involved in the control of cell division and growth. 
Reproduction in unicellular organisms are referred to cell division and in multicel-
lular organisms it is tissue growth and maintenance. Survival of the eukaryotes 
depends upon interactions between various cell types, that helps in the balanced 
distribution. This is achieved through the highly regulated process of cell prolifera-
tion. Knowledge in cell cycle is necessary to determine the best time to collect cells, 
to harvest cell products, or to move cells to a new growth environment. Cancer cells 
do not die at the natural point in a cell’s life cycle. Cancer cells occur as the results 
of cellular changes caused by the uncontrolled growth and division of cells. The 
chapter focuses on cancer cell maintenance, apoptosis, and its detection assays.
Keywords: cancer cell maintenance, apoptosis, cytotoxicity, cell-based assays
1. Introduction
Cell division and the increase in cell quantity is called cell growth. Cell growth 
happens in favorable nutrient conditions. It is the process by which cells accumulate 
mass and increase in physical size. The growth of tissues that are not self-renewing 
occurs by a combination of increase in number and increase in size of the compo-
nent cells. Cells will progress unimpeded through the cell cycle and divide; one cell 
will become two, two will become four, four will become eight, and so on. Cellular 
growth is ensured by the alternation of DNA duplication and cell division cycles [1]. 
When the cell reaches maximum size, the important point is that the surface area to 
the volume ratio becomes smaller as the cell gets larger. When the cell grows beyond 
a certain limit, inadequate material will be able to cross the membrane sufficient 
to accommodate the increased cellular volume. Increase of size and change in 
shape of a developing organism depend on the increase in the number and size of 
cells. The increase in cell number is due to cellular reproductive mechanism called 
mitosis. Cells are limited to their programmed size because the cell membrane must 
transport oxygen and food into the cell, as well as transport waste like CO2 and H2O 
out of the cell. As the cell grows, the inside grows faster than the outside. Cellular 
growth is ensured by the alternation of DNA duplication and cell division cycles. As 
the cell grows, the inside grows faster than the outside. Cellular growth is ensured 
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by the alternation of DNA duplication and cell division cycles; through transcrip-
tion the coupling of cell divisions is taking place in metabolic pathways [2].
Cancer cell growth: cancer is a condition where cells grow uncontrollably in 
a specific part of the body. Cancerous cells can invade and destroy surrounding 
healthy tissue and organs. Cancer cells divide relentlessly, forming solid tumors or 
flooding the blood with abnormal cells. Cell division is a normal process for growth 
and repair. A parent cell divides to form two daughter cells and is used to build 
new tissue, or it is used to replace cells that have died because of aging or damage. 
Healthy cells stop dividing when there is no longer a need for more daughter cells, 
but cancer cells continue the divisions. They are capable of spreading from one part 
of the body to another in a process known as metastasis [3]. Cell proliferation and 
cell death are such diametrically opposed cellular fates that are linked and interde-
pendent processes [4, 5].
Cell culture refers to the removal of cells from an animal or plant and their sub-
sequent growth in a suitable artificial environment. In vitro assays are performed 
to check the proliferation that reflects cellular responses to various stimuli. These 
techniques help to observe cell division and quantity of cells. Cell culture technol-
ogy shows a good progress in biology and is heavily dependent on cell culture 
technology. Chemotherapeutic agent phenoxodiol, a synthetic analog of daidzein, a 
well-known isoflavone from soybean (Glycine max) was developed as a therapeutic 
agent against cervical, ovarian, prostate, renal, and vaginal cancers. They induce 
apoptosis through the inhibition of antiapoptotic proteins [6]. Apoptotic shrinkage, 
disassembly into apoptotic bodies, and engulfment of individual cells characteristi-
cally occur without associated inflammation. This could then be the consequence 
of releasing intracellular contents into tissues. This could be the consequence of 
releasing intracellular contents into tissues; the mitochondria remain unchanged 
morphologically [7].
1.1 The intrinsic pathway for programmed cell death
The signaling pathway for programmed cell death involves non-receptor-
mediated intracellular signals inducing activities in the mitochondria that initiate 
apoptosis. Stimuli for the intrinsic pathway are caused by viral infections or dam-
age to the cell by toxins, free radicals, or radiation. Damage to the cellular DNA 
can also induce the activation of the intrinsic pathway for programmed cell death 
[8]. Proapoptotic proteins activate caspases to mediate the destruction of the cell 
through different pathways. These proteins translocate to the nucleus of cells, 
thereby inducing DNA fragmentation which is a hallmark of apoptosis. The mem-
bers of the Bcl-2 family of proteins and the tumor suppressor protein p53 regulate 
proapoptotic event in the mitochondria (Figure 1a). The Bcl-2 family members of 
proteins may be pro- or antiapoptotic. Bcl-2, Bcl-x, Bcl-xL, Bcl-XS, Bcl-w, and BAG 
are the antiapoptotic proteins. These proteins are currently under investigation as 
potential targets for anticancer therapy. Bcl-10, Bax, Bak, Bid, Bad, Bim, Bik, and 
Blk are proapoptotic proteins. The upregulation of these proteins or their increased 
activation may offer an approach for cancer therapy [9]. Cellular pathways that 
modulate the activities of the p53 protein are also currently being evaluated as 
targets for potential anticancer therapies [10].
1.2 The extrinsic pathway for programmed cell death
The extrinsic signaling pathway leads to apoptosis that is through transmem-
brane death receptors, members of the tumor necrosis factor (TNF) receptor 
gene super family. Members of this receptor family bind to extrinsic ligands and 
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transduce intracellular signals that result in the destruction of the cell [11]. The 
most well-characterized ligands of these receptors are FasL, TNF-alpha, Apo3L, 
and Apo2L, and its corresponding receptors are FasR, TNFR1, DR3, and DR4/DR5, 
respectively [8, 9, 12]. Molecules that stimulate the activity of these proapoptotic 
proteins or activate these receptors are currently under the evaluation for their 
therapeutic potential in the treatment of cancer, including hematologic malignan-
cies. The signal transduction of extrinsic pathway involves various caspases which 
are proteases with specific cellular targets. Once activated, the caspases affect 
several cellular functions as part of a process that results in the death of the cells [8]. 
This visible transformation of apoptosis is accompanied by biochemical changes. 
Those at the cell surface include the externalization of phosphatidyl serine and 
other alterations that promote recognition by phagocytes. Intracellular changes 
include the degradation of the chromosomes of the chromosomal DNA into high 
molecular weight and oligonucleosomal fragments and cleavage of a specific subset 
of cellular polypeptide [13, 14]. These cleavages are accompanied by a family of 
intracellular proteases called caspases (Figure 1b).
2. 2D and 3D cell culture systems
Cell culture is used in vitro in cell biology, tissue morphology, and mechanisms 
of diseases, drug action, protein production, and the development of tissue engi-
neering. The stage of the culture after the cells can be isolated from the tissue and 
proliferates under favorable conditions until they reach confluency. In this stage, 
the cells have to be passaged or subcultured by transferring them to a new vessel 
with fresh growth medium to provide more room for continued growth. Various 
researches in cancer biology are based on experiments using two-dimensional cell 
culture by growing cells in flat dishes, made of plastic. The dish culture system is 
mainly used for developing adherent two-dimensional cell monolayers. 3D cell 
culture applications are usually beneficial in tissue engineering and regenerative 
Figure 1. 
(a) The intrinsic pathway for programmed cell death. (b) The extrinsic pathway for programmed cell death.
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medicine. 3D cell culture is an artificially created environment in which biological 
cells are allowed to grow and interact with their surroundings in all three dimen-
sions. These three-dimensional cultures are grown in bioreactors, small capsules in 
which the cells can grow into spheroids, otherwise 3D cell colonies. Approximately 
300 spheroids are usually cultured per bioreactor 3D cell culture which allows cells 
in vitro to grow in all directions, similar to how they would in vivo [15]. An increas-
ing shift in research is occurring, where 3D cell culture systems are replacing 2D cell 
culture systems and translating 2D in vitro research to 3D before or as an alternative 
to testing using in vivo animal models [16, 17].
2.1 Preparation of culture media
Culture media provide artificial environment to grow the cancer cells in vitro. 
Culture media can be prepared by mixing DMEM powder (glucose, l-glutamine, 
pyridoxine, HCl, without pyruvate) in autoclaved triple distilled water. To this 
1.95 g of HEPES buffer and 3.75 g sodium bicarbonate can be added. Antibiotics 
such as penicillin (500 μl) and streptomycin (500 μl) and fungicide-amphotericin-
B (750 μl) can also be added. The volume can then be made up to 1000 ml, and 
the pH will adjust to 7.2–7.4. The medium will then filter under negative pressure 
using 0.22 μm cellulose filter. Sterility of the medium can be tested before use. Ten 
percent FCS can be mixed with the medium prior to culture.
2.2 Maintenance of adherent cancer cell lines
Adherent cell lines will grow in vitro until they form a monolayer over surface 
area available or medium depleted of nutrients. Adherent cells human oral cancer 
cells (KB), lung adenocarcinoma (A-549), and breast cancer (MCF-7) can be 
cultured in tissue culture flasks. The cells were disaggregated by trypsinization and 
subcultured when the monolayer reaches about 70% confluency. The cells will be 
cryopreserved at −80°C. With an inverted microscope, the degree of confluency of 
the cell monolayer can be assessed, and the absence of bacterial and fungal con-
taminants can be confirmed. Spent medium can be removed. Cells can be washed 
with PBS-EDTA for removing the traces of serum. Trypsin/EDTA (500 μl) will be 
applied onto the cell monolayer, and the flask is swirled to cover the monolayer with 
trypsin. The flask will be incubated at 37°C for 2–3 min. The flask can be examined 
under the inverted microscope to ensure uniform detachment of the cells. 1–2 ml of 
medium can be added to the flask as fast as possible to lessen the trypsin-induced 
stress, and the contents of the flask can be transferred to a centrifuge tube. Cells 
should be centrifuged at 1500 rpm, for 10 min. The supernatant will be discarded, 
and the cells were resuspended in minimum volume of medium. Cells can be 
counted using a hemocytometer, and the required numbers of cells can be subcul-
tured in a new flask containing fresh DMEM with 10% FCS. This process can be 
repeated as demanded by the growth characteristics of the cell line.
2.3 Maintenance of cancer suspension cell lines
In general terms cultures derived from blood (e.g., lymphocytes grow in sus-
pension) cells may be seen as single cells or clumps. For these types of cell lines, 
subculturing is done by dilution in small volume of media before counting. The 
culture can be viewed using an inverted phase contrast microscope; cells growing in 
exponential phase should be bright, round, and refractive. Cell suspension can be 
mixed well and dispersed uniformly by repeated pipetting in order to make single-
cell suspension. The cells can be counted, and 1 × 106 cells can be seeded to a fresh 
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bottle containing 10 ml of DMEM medium with 10% FBS antibiotics and incubated 
at 37°C and subcultured every third day. On the day of the experiment, single-cell 
suspension will be prepared. The cells will be counted and the viability can be 
checked. The concentration can be adjusted with the medium containing 10% FBS 
and antibiotics.
2.4 Establishing cell cultures from frozen cells
About 10 ml of growth medium placed in a 15-ml conical tube. Thaw the frozen 
cryovial of cells for 40–60 s by gentle agitation in a 37°C water bath. Remove the 
cryovial from the water bath, and decontaminate the cryovial by immersing it in 
70% (v/v) ethanol at room temperature (RT). Transfer the thawed cell suspension 
to the conical tube containing 10 ml of growth medium. Cells can be collected 
by centrifugation at 2000 rpm for 5 min at RT. Remove the growth medium by 
aspiration, and then resuspend the cells in the conical tube in 5 ml of fresh growth 
medium. Add 10 ml of growth medium to a 75-cm2 tissue culture flask, and transfer 
5 ml of cell suspension to the same. Place the cells in a 37°C incubator at 5% CO2. 
Monitor cell density daily. Cells can be passaged when it will attain 50% confluency.
3. Determination of cell viability by trypan blue exclusion method
Trypan blue is a dye used to determine the viability of a cell. Living cells exclude 
the dye, and dead cells will take up the blue dye. The blue stain is easily visible, and 
cells can be counted using a light microscope. The reactivity is negatively charged 
and does not interact with the cell unless the membrane is damaged. Therefore, all 
the cells that exclude the dye are viable. When the cells are confluent, remove the cell 
media through aspiration, and add 5 ml of PBS swirl and aspirate. Then add 2 ml of 
trypsin/EDTA, and swirl to cover the monolayer of cells. Incubate for few minutes 
at 37°C. To remove the cells, strike the side of the plate or the flask with the palm. 
Check under a microscope to ensure that all the cells are dislodged. Add 8 ml of cell 
media containing fetal calf serum (FCS) to the cells containing the culture flask. 
The FCS will neutralize the action of trypsin. Transfer the cell suspension to a sterile 
centrifuge tube, and centrifuge the cell suspension at 1000g to pellet the cells. Wash 
the cell pellet twice with PBS. Resuspend the cell pellet in appropriate volume of PBS 
or cell media. Dilute 10 μl of cell suspension, and place 10 μl on a hemocytometer, 
and count the cells under a microscope. There are grid markings on the hemocytom-
eter that can be seen under magnification. Count the cells in all four other quadrants 
of the grid. Divide this number by four to determine the average number of cells in 
one quadrant. To calculate the number of cells, multiply the average number of cells 
per quadrant by dilution factor. Multiply this number by 10,000 to calculate the 
number of cells in 1 ml of suspension. The equation is as follows: average number of 
cells per quadrant C dilution factor C 10,000 = number of cells/ml. To calculate the 
total number of cells, multiply the number of cells per ml by the volume (ml) of the 
cell suspension.
Calculating the % of viable cells: The cells (10,000) are suspended in 500 μl 
media and treated with varying concentrations of drug and incubate for 24 h. 
Centrifuge at 1500 rpm for 10 min. Discard 400 μl medium. Resuspended the 
pellet in the remaining medium. Mix 0.5 mg of trypan blue in 1 ml PBS. Take 10 μl 
of cell suspension and mix with trypan blue solution. Incubate for 5 min at room 
temperature. Count the numbers of unstained cells on the hemocytometer under a 
microscope. As mentioned above the dead cells will take up the trypan blue stain. 
First count the blue cells in the field and then white cells. Count the total number of 
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cells. The percentage of viable cells can be determined by dividing the number of 
unstained cells by the total number of cells and multiplying by 100. The equation is 
as follows: % of Cytotoxicity = [No. of blue cells/Total no. of cells] × 10.
3.1 Evaluation of cytotoxicity using MTT assay
The assay detects the living cells, and it be used to measure cytotoxicity, pro-
liferation, or activation [18]. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra-
zolium bromide] assay is based on the principle that mitochondrial dehydrogenase 
enzyme forms viable cells to cleave the tetrazolium rings of the pale yellow MTT 
and forms a dark blue formazan crystal which is largely impermeable to cell mem-
branes, thus resulting in its accumulation within healthy cells. The solubilization of 
the cells is by the addition of a detergent that cause in the liberation of the crystals, 
which are solubilized. The color can be quantified using a multi-well plate reader 
at 570 nm. The cells can be maintained in DMEM medium, supplement with 10% 
FCS. Briefly, cells in the log phase of growth can be harvested, counted, and seed  
(5 × 103 cells/well in 100 μl) in 96 well titer plates (Axygen), and add PBS to the 
outer wells (200 μl/well). After 24 h of incubation at 37°C in 5% CO2 to allow cell 
attachment, media will be removed; cultures will be treated with various concentra-
tion of compounds diluted with medium. Cells and media are used as the negative 
controls. The plates are further incubated for 24, 48, and 72 h. On completion of 
incubation, with the extract, media can be removed without disturbing the adher-
ent cells. In the case of suspension cells lines, the media can be removed after the 
plates are centrifuge at 2000 rpm for 15 min. To each well, 100 μl of 5 mg/ml stock 
solution of MTT dye will be added, and plates can be incubated for 2 h in the dark at 
37°C in a CO2 incubator. About 100 μl of lysis buffer can be added to each well, and 
the plates can be incubated for 4 h in the dark in a CO2 incubator and absorbance 
can be read using ELISA plate reader. Three replicates are set up for each concentra-
tion. The concentration required to reduce absorbance by 50% (IC50) in comparison 
to control cells is determined. In MTT assay colorless well indicates the cytotoxicity 
of KB human oral cancer cells (Figure 2)
 1 % of Growth inhibition  =  100 −  Absorbance of treated cells × 100 _________________________  
Absorbance of control cells
                      (1)
3.2 WST-1 assay
This method is used to detect the cytotoxicity of compound towards vari-
ous cancer cell lines. The mitochondrial dehydrogenase enzyme cleaves the 
tetrazolium salt to formazan. The amount of the dye generated by the activity of 
Figure 2. 
MTT assay: purple color indicate the viability of cells.
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dehydrogenase is directly proportional to the number of living cells. In the WST-1 
assay protocol, add the WST-1 assay reagent to the cell culture media, and incubate 
for between 0.5 and 4 h, shake well. The formazan crystals produced by viable cells 
can be quantified and can be read in microplate reader at 440 nm. Cellular pro-
liferation represents the ability of healthy cells to divide and create progeny [19]. 
Therefore, cell viability assays and cell proliferation assays are used to calculate 
the number of healthy cells in a population or the rate of growth of a population of 
cells [20].
3.3 MTS assay
MTS is a colorimetric method used to quantify viable cells in proliferation assay. 
The NAD(P)H-dependent dehydrogenase enzymes in metabolically active cells 
reduce the MTS tetrazolium compound and form colored formazan product that is 
soluble in cell culture media. It can be used to test cell proliferation, cell viability, 
and cytotoxicity. The formazan dye can be quantified by measuring the absorbance 
at 490–500 nm.
4. Viability assay in normal cells
Attempts are pursued to develop drugs that are nontoxic to normal cells; mean-
while toxic to cancer cells can be considered as good anticancer agent.
4.1 Isolation of lymphocytes from whole blood
In 1968, Boyum [21] described methods for the isolation of mononuclear cells 
from circulating blood and bone marrow. The solution contains Ficoll and sodium 
diatrizoate, adjusted to a density of 1.077 ± 0.001. This medium facilitates rapid 
recovery of viable lymphocytes from small volumes of blood on centrifugation. 
It is usually employed as the initial isolation step prior to enumeration of T, B, 
and null lymphocytes. In brief, 3 ml of blood will be taken in heparinized test 
tube. About 5 ml of PBS will be added and mixed well by inversion. About 3 ml 
of Ficoll Hypaque solution was added in a conical centrifuge tube. Carefully 
layered 8 ml of blood-PBS mixture on to the Ficoll Hypaque, keeping the tube in 
a slanting position. Centrifuged at 2000 rpm for 30 min. The opaque interface 
containing mononuclear cells was aspirated and transferred into a clean conical 
centrifuge tube with a Pasteur pipette and discard the upper layer. About 10 ml 
of PBS solution was added and mixed by inversion. Centrifuged at 1500 rpm for 
10 min and the supernatant was discarded. Resuspend the pellet with 5 ml PBS 
and centrifuge at 1500 rpm for 10 min. Repeat the step thrice and resuspend the 
lymphocyte pellet in 500 μl PBS.
4.2 Lymphocyte viability assay
In vitro experiments with compounds can be tested in lymphocyte using 
lymphocyte viability assay. The lymphocytes were aspirated from the gradient 
plasma interfaces and washed twice in PBS, and then the final cell pellets will be 
resuspended in RPMI-1640 medium containing 10% FCS and 100 μl streptomycin, 
and 100 μl fungicide can be added to avoid contamination; pH 7.4 is ideal. Cells 
can be harvested, counted, and seeded (5 × 103 cells/well in 100 μl) in 96 well 
titer plates (Axygen). PBS will be added to the outer wells (200 μl/well). After 
24 h of incubation at 37°C in 5% CO2 to allow cell attachment, the media will be 
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Figure 3. 
Comet assay: (a) non-apoptotic cells, (b) comet-shaped apoptotic cells.
removed. Cells will be treated with varying concentration of compounds diluted 
with medium. The plates can be incubated for 72 h. After incubation, the media 
will be removed without disturbing the cells, and to each well, 100 μl of 5 mg/ml 
stock solution of MTT will be added, and the plates can be incubated for 2 h in the 
dark at 37°C in a CO2 incubator. About 100 μl of lysis buffer will be added to each 
well, and the plates can be further incubated for 4 h in the dark in a CO2 incubator, 
and absorbance can be read using ELISA plate. Three replicates will set up for each 
concentration.
5. Detection of apoptosis by comet assay
Comet assay can be done for the quantitation of low levels of DNA damage in 
individual [22]. Cancer cells except the control cells can be treated with various 
drugs. Then it can be centrifuged to get the pellets, and pour 1% NMPA agar on the 
base slides using filler pipette and allow to solidify. Then the slides were kept in a 
polar ice pack. The pellets thus obtained will be taken and is mixed with 200 μl of 
0.5% LMPA agar. About 15 0 μl cells from the above tubes were taken and poured 
over the base slides, and allow to solidify after placing a cover slip over it, and then 
remove the cover slip and pour a layer of 1% LMPA agar over it, and allow to solidify 
and keep these slides in a coupling jar containing lysing solution. It will be kept in 
refrigerator for 1:30 h, and subject it to electrophoresis for 20–30 min in electro-
phoresis apparatus at 25 V. Then the slides were taken and washed with neutralizing 
buffer solution for three times. Pour ethidium bromide stain over the slides, and 
view through fluorescent microscope. The figure shows the comet assay on KB 
human oral cancer cells after treatment with compound for 24 h (Figure 3).
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5.1 DNA ladder assay
Breakdown of genomic DNA into multiples of approximately 180 bp is considered 
to be a hallmark of apoptosis [14]. This cleavage of chromosomes produces a large 
number of DNA breaks, and subsequently a simultaneous amount of new 3′-OH DNA 
ends. In normal living cells, only an insignificant number of 3′-ends are present; this 
helps to detect apoptosis. The enzyme terminal deoxynucleotidyl transferase (TdT) 
has the capability to incorporate individual deoxyribonucleotide triphosphates to the 
3′-end of double- or single-stranded DNA. This quality can be detected using 3′-ends 
with nucleotides that have been labeled with radioactive, fluorescent, or digoxigenin 
labels. Apoptosis can be measured quantitatively by using gel electrophoresis; here the 
apoptotic DNA is organized into a typical ladder pattern of multiples of 180 bp. In situ 
labeling of 3′-ends can be used to detect qualitatively apoptotic cells (Figure 4).
5.2  Detection of morphological features of apoptotic cells by acridine orange-
ethidium bromide dual staining
The morphological features of apoptosis induced by the compounds will be evalu-
ated by acridine orange-ethidium bromide dual (AO/EtBr) staining [23]. Briefly, cells 
Figure 4. 
Apoptotic cells can be seen as fragmented DNA in smear appearance.
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Figure 6. 
Hoechst 33342: (a) non-apoptotic cells in blue color, (b) apoptosis cells in fluorescent blue color.
will be seeded in a 96 well plate at a density of 5 × 105 cells and treat with different 
concentrations of compound for 24 h. After washing once with PBS, the cells can be 
stained with 100 μl of a mixture (1:1) of acridine orange-ethidium bromide (4 μg/
ml) solutions. The cells can be immediately washed with PBS and observed under 
fluorescence microscope at 450–490 nm. The effects of the compound treated on 
human oral cancer cells (KB) for 24 h can be visualize using fluorescent microscope 
(Figure 5).
5.3 Analysis of cell death by Hoechst 33342 staining
Chromatin condensation will be assessed by nuclear staining with Hoechst 
33342 [24]. Briefly, cells will be seeded in a 96 well plate at a density of 5 × 105 cells 
and then treated with different concentrations of compounds for 24 h. After wash-
ing once with PBS, the cells will be stained with 100 μl of Hoechst 33342 (10 mg/
ml stock) and incubate at room temperature for 5 min. Stained cells can be imaged 
by fluorescence microscope at 350–460 nm compound induced in KB human oral 
cancer cells for 24 h, stained with Hoechst 33342 (Figure 6).
5.4  Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling 
(TUNEL) assay
After treatment with the compound apoptosis, induction can be detected by 
TUNEL assay using the DeadEnd apoptosis detection kit (dUTP nick-end labeling 
Figure 5. 
Acridine orange-ethidium bromide dual staining: (a) and (b) apoptotic cells in orange color, live cells in green 
color.
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TUNEL assay) from Promega (Madison, USA). Briefly, the cells will be grown in 
coverslips and treated with the compound for 24 h. The cells can be washed with 
phosphate-buffered saline and fix by immersing the slides in 4% paraformaldehyde 
for 25 min at room temperature, washed twice with PBS for 5 min. The cells will be 
permeabilized with 0.2% Triton X-100 solution in PBS for 5 min, washed twice in 
PBS, and then covered with 100 μl of equilibration buffer and kept for 5–10 min. The 
equilibrated areas will be blotted around with tissue paper, and 100 μl of terminal 
deoxynucleotidyl transferase (Tdt) reaction mix will be added to the sections on 
the slide and incubated at 37°C for 60 min inside a humidified chamber for the 
end labeling reaction to occur. Immersing the slides in 2× sodium chloride-sodium 
citrate buffer for 15 min terminated the reactions. The slides will be washed thrice by 
immersing in fresh PBS for 5 min to remove the unincorporated biotinylated nucleo-
tides. The endogenous peroxidase activity was blocked by immersing the slides in 
0.3% hydrogen peroxide. After washing, horse radish peroxidase-labeled streptavi-
din solution was applied, and the slides incubated for 30 min. After incubation, the 
color will be developed with the peroxidase substrate (hydrogen peroxide) and the 
stable chromogen (diaminobenzidine). The slides will be mounted and examined in 
a light microscope. The apoptotic index (AI) can be calculated as follows: AI = (num-
ber of apoptotic cells/total number) × 100%. TUNEL can also be combined with 
annexin V to comprise a more robust assay that is capable of distinguishing apoptosis 
and necrosis going on in the cells. Since annexin V binding is reported to occur prior 
to DNA fragmentation, it is capable of detecting necrotic or early apoptotic cells that 
exhibit a negative response from TUNEL [25]. In KB human oral cancer cells treated 
with compound for 24 h, apoptotic cells can be seen in green color (Figure 7).
5.5 Annexin V staining by flow cytometry
In most normal, viable eukaryotic cells, the negatively charged phospholipid 
phosphatidylserine (PS) is located in the cytosolic leaflet of the plasma membrane 
lipid bilayer. Annexin V is a 36 KDa phospholipid-binding protein and has a high 
affinity to PS in the presence of physiological concentrations of calcium (Ca2+). 
Apoptotic cells which are otherwise undetectable by staining with propidium iodide 
(PI) can be directly detected through the staining with fluorochrome-conjugated 
annexin V. Dead cells are stained with both annexin V and PI, whereas viable cells 
cannot be stained with either annexin V or PI. An early indicator of apoptosis is the 
rapid translocation and accumulation of the membrane phospholipid. Phosphatidyl 
serine from the cytoplasmic interphase translocated to the extracellular surface. This 
loss of membrane asymmetry was detected using the binding properties of annexin 
V to phosphatidyl serine. Annexin V FITC is a sensitive probe for identifying the 
Figure 7. 
TUNEL assay.
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apoptotic cells which binds to negatively charged phospholipid surfaces. Annexin V 
FITC staining precedes the loss of membrane integrity which accompanies the later 
stages of cell death resulting from apoptotic or rather necrotic process. Therefore, 
staining with annexin V FITC is conjugated to vital dye propidium iodide. The assay 
distinguishes between viable cells (annexin V –ve, PI –ve), early apoptotic cells 
(annexin +ve PI –ve), late apoptotic cells (annexin +ve PI +ve), and necrotic cells 
(annexin –ve PI +ve) (Figure 8). Annexin V is represented in red. An apoptotic cell 
stained with annexin V (green) is surrounded by potential phagocytes. The PSR 
(orange) might bind to exposed PS that is configured in a recognizable “eat-me” form 
by annexin I (bottom) (Figure 8). Alternatively, PSR might bind to a ligand composed 
of PS and annexin I (upper left) or PSR might bind annexin I, which serves as a bridge 
between exposed PS on the dying cell and PSR on the phagocyte (upper right) [26].
5.6 Assessment of caspase 3 expression by flow cytometry
Caspase-3 is a key protease that is activated during apoptosis. Briefly, the cells 
will be treated with various concentrations of compound. After 24 h of incubation, 
the cells will be washed twice with cold PBS and prepared for acquisition using 
FITC conjugated monoclonal active caspase-3 antibody apoptosis detection kit. The 
cells can be fixed in cytofix solution at a concentration of 1 × 106 cells/0.5 ml. The 
cells will be fixed in ice for 30 min, resuspended in perm wash buffer containing 
antibody, and incubated for 30 min at room temperature. Analyses by flow cytom-
etry. 10,000 cells can be acquired, and the results can be interpreted using DIVA 
software analysis (Figure 9).
5.7 Determination of caspase activity by fluorimetry
The ApoAlert caspase assay plates contain the fluorogenic substrates specific 
for different caspases immobilized in the wells of a 96-well plate. When cell lysate 
containing the active caspase is applied to the wells, caspase will cleave its substrate, 
and a fluorescent product will be released that can be detected with a standard 
fluorescence plate reader. Caspase assay plates enable the analysis of the apoptotic 
caspase response. This assay design is ideal for studies involving multiple cell types 
or multiple cell treatments. These plates are provided in two formats: a single 
caspase format for studies that focus on a specific caspase or a profiling format for 
analyzing several different caspases simultaneously (caspase-3, caspase-8, cas-
pase-9, and caspase-2).
Figure 8. 
Apoptotic KB human oral cancer cells after treatment with compound showing apoptosis.
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5.8 Detection of apoptosis by cell cycle analysis
The phase of the cell cycle at which compounds treated cancer cells got arrested 
can be determined using a fluorescent-activated cell sorter (FACS—Becton 
Dickinson). The cells will be grown in tissue culture flasks and treat with different 
concentrations of compounds. After 24 h of treatment, the cells can be harvested 
and spun down at 3500 rpm for 7 min. The cells can be then fixed in 70% ethanol 
for 30 min. After centrifugation, the pellet can be dissolved in PBS, and 5 μl of 
RNAse A (10 mg/ml) will be added and incubated for 30 min at 37°C. About 10 μg/
ml of propidium iodide will be added, and after 15 min of incubation in the dark, 
the cells can filtered through 0.75 μm filter and analyzed by flow cytometry. Thirty 
thousand cells can be acquired, and the results can be interpreted using CellQuest 
Pro software analysis (Figure 10).
6. Conclusions
An ideal compound should possess no toxic effects on normal human lym-
phocyte but at the same time exhibited cytotoxic activity on tumor cell lines. The 
time- and dose-dependent cytotoxic effect of the compound can be tested through 
Figure 9. 
Caspase 3 cleavage of KB human oral cancer cells.
Figure 10. 
Cell cycle analysis showing KB human oral cancer cells.
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the various viability assays discussed in this chapter. The compound might have 
the potential to induce programmed cell death in cancer cells and can be confirmed 
through apoptotic studies. Induction of apoptosis in cancer cells is recognized as 
an efficient strategy for cancer chemotherapy. Apoptosis also seems to be a reliable 
marker for the evaluation of potential agents to bring out for cancer prevention. 
Cell-based assays are useful for the assessment of live cells and apoptotic cells 
after treatment with therapeutic agents. The efficacy of compounds in vitro test-
ing before entering into the clinical trials helps to bring out potent drugs into the 
limelight for the treatment of diseases. Cell-based assays are useful for evaluating 
therapeutic potency of the developing approved drugs and biologics for the clinical 
management of cancer.
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